pharma · Cystic Fibrosis · Hepatitis C
Vertex Pharmaceuticals (Australia)
Vertex Pharmaceuticals (Australia) Pty.
Vertex Pharmaceuticals (Australia) patent portfolio — 57 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Vertex Pharmaceuticals Inc., 50 Northern Avenue, Boston, MA 02210, US
- Founded
- 1989
- Employees
- 6,304
- Programs
- 0
- Drugs
- 37
- Patents
- 57
Vertex Pharmaceuticals (Australia) patents
57 pharmaceutical patents indexed for Vertex Pharmaceuticals (Australia). 0 expire within 24 months.
Vertex Pharmaceuticals (Australia) has 57 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 8431615
Dose forms
granted -
US 8415387
Modulators of ATP-binding cassette transporters
granted -
US 8410274
Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
granted -
US 8354427
Modulators of ATP-binding cassette transporters
granted -
US 8324242
Modulators of ATP-binding cassette transporters
granted -
US 7973038
Modulators of ATP-binding cassette transporters
granted -
US 7776905
Modulators of ATP-binding cassette transporters
granted -
US 7645789
Indole derivatives as CFTR modulators
granted -
US 7495103
Modulators of ATP-binding cassette transporters
granted
Frequently asked questions
How many patents does Vertex Pharmaceuticals (Australia) have?
57 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Vertex Pharmaceuticals (Australia) patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.